Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dwyer

Showing results (21-30 of 260) with videos related to

Pageof 26
Sort By:
Current Topics in Medicinal Chemistry|June 12, 2010
Discovery of 3,4-diaminocyclobut-3-ene-1,2-dione-based CXCR2 receptor antagonists for the treatment of inflammatory disordersMichael P Dwyer, Purakattle Biju
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 21, 2022
New Directions in Phosphorus Management in DialysisJamie P Dwyer, Ellie Kelepouris
Nauchnye Doklady Vysshei Shkoly. Biologicheskie Nauki|January 1, 1990
[The demonstration of an extramembranous location for the putative amphipathic helix of the acetylcholine receptor]B P Dwyer, J Kyte
Health Progress (Saint Louis, Mo.)|July 30, 2008
Palliative care and community benefit can work togetherDaniel P Dwyer, Julie Trocchio
Expert Opinion on Therapeutic Patents|February 22, 2014
CXCR2 modulators: a patent review (2009 - 2013)Michael P Dwyer, Younong Yu
Current Topics in Medicinal Chemistry|August 28, 2014
CXCR2 receptor antagonists: a medicinal chemistry perspectiveMichael P Dwyer, Younong Yu
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 2, 2011
Olmesartan to prevent the development of microalbuminuria: is it new? Is it true? Is it important?Jamie P Dwyer, Julia B Lewis
Journal of Orthopaedic Surgery (Hong Kong)|March 5, 2019
Venous thromboembolism after hospital discharge in pelvic and acetabular fracture patients treated operativelyEmma P Dwyer, Berton R Moed
European Urology|March 26, 2004
Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladderF Haab, L Stewart, P Dwyer
Evidence-Based Medicine|November 6, 2012
Lactobacillus probiotics may prevent recurrent UTIs in postmenopausal womenJeremy P Dwyer, Peter L Dwyer
Pageof 26

Showing results (21-30 of 260) with videos related to

Sort By:
Pageof 26
Current Topics in Medicinal Chemistry|June 12, 2010
Discovery of 3,4-diaminocyclobut-3-ene-1,2-dione-based CXCR2 receptor antagonists for the treatment of inflammatory disordersMichael P Dwyer, Purakattle Biju
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 21, 2022
New Directions in Phosphorus Management in DialysisJamie P Dwyer, Ellie Kelepouris
Nauchnye Doklady Vysshei Shkoly. Biologicheskie Nauki|January 1, 1990
[The demonstration of an extramembranous location for the putative amphipathic helix of the acetylcholine receptor]B P Dwyer, J Kyte
Health Progress (Saint Louis, Mo.)|July 30, 2008
Palliative care and community benefit can work togetherDaniel P Dwyer, Julie Trocchio
Expert Opinion on Therapeutic Patents|February 22, 2014
CXCR2 modulators: a patent review (2009 - 2013)Michael P Dwyer, Younong Yu
Current Topics in Medicinal Chemistry|August 28, 2014
CXCR2 receptor antagonists: a medicinal chemistry perspectiveMichael P Dwyer, Younong Yu
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 2, 2011
Olmesartan to prevent the development of microalbuminuria: is it new? Is it true? Is it important?Jamie P Dwyer, Julia B Lewis
Journal of Orthopaedic Surgery (Hong Kong)|March 5, 2019
Venous thromboembolism after hospital discharge in pelvic and acetabular fracture patients treated operativelyEmma P Dwyer, Berton R Moed
European Urology|March 26, 2004
Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladderF Haab, L Stewart, P Dwyer
Evidence-Based Medicine|November 6, 2012
Lactobacillus probiotics may prevent recurrent UTIs in postmenopausal womenJeremy P Dwyer, Peter L Dwyer
Pageof 26